End user conditions of product sale

Choose your country

Select your country

Did you know? Fujirebio and Covid-19

In a reply to the Covid-19 pandemic, that has been impacting the world since early 2020, Fujirebio has played an important role as a partner, offering various testing solutions that are used across the world today.

Read more here

Please note that the conditions below are for Fujirebio Europe end user customers.

For conditions of sale for our Fujirebio Diagnostics AB customers (mostly EIA tumor markers and raw materials) or if you have any doubts please contact us.

Conditions of sale Fujirebio